| Not Yet Recruiting | Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune R Ebola Virus Disease | Phase 2 | 2027-01-01 |
| Not Yet Recruiting | EBOla Post-Exposure Prophylaxis Ebola Virus Disease | Phase 3 | 2026-09-01 |
| Not Yet Recruiting | Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication A HIV-1-infection | Phase 2 | 2026-05-01 |
| Not Yet Recruiting | Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa Older Adults | — | 2026-03-01 |
| Not Yet Recruiting | "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort" HIV Infection, HBV Infection, HDV Infection | — | 2026-02-01 |
| Not Yet Recruiting | "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission" HBV Infection, Pregnancy | N/A | 2025-11-01 |
| Not Yet Recruiting | Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Japanese Encephalitis | — | 2025-10-15 |
| Not Yet Recruiting | Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Hepatitis C Virus Infection | Phase 4 | 2025-09-01 |
| Not Yet Recruiting | Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patien HIV Seropositivity, HIV Drug Resistance, HIV Infections | — | 2025-09-01 |
| Not Yet Recruiting | HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM) HIV Infection | — | 2025-06-30 |
| Recruiting | Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers Healthy Volunteers | Phase 1 / Phase 2 | 2025-06-18 |
| Not Yet Recruiting | Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB) Tuberculosis | — | 2025-06-01 |
| Recruiting | Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults Healthy | Phase 1 / Phase 2 | 2025-05-09 |
| Not Yet Recruiting | A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 HIV-1-infection | N/A | 2025-04-01 |
| Not Yet Recruiting | Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025) HIV Infection | — | 2025-04-01 |
| Recruiting | Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Pre HPV Infection, Anal Cancer | N/A | 2025-03-20 |
| Not Yet Recruiting | Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief HIV Infections, HBV Coinfection | Phase 2 | 2025-02-01 |
| Recruiting | DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infec HIV-1-infection | Phase 3 | 2025-01-27 |
| Not Yet Recruiting | Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination HIV Infections, Yellow Fever | N/A | 2024-11-01 |
| Recruiting | Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France. HIV/AIDS | Phase 3 | 2024-06-05 |
| Not Yet Recruiting | Pilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a Respondent Driven Sampli HIV Infections | — | 2024-06-01 |
| Not Yet Recruiting | Assisted Notification of Partners of Men Having Sex With Men Discovering Their Seropositivity HIV Infections | N/A | 2024-06-01 |
| Recruiting | Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a B COVID-19 | Phase 1 / Phase 2 | 2024-05-27 |
| Recruiting | Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in HIV Infections | N/A | 2024-05-02 |
| Recruiting | Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control HIV/AIDS and Infections | Phase 2 | 2024-04-11 |
| Not Yet Recruiting | Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. Prevention | Phase 3 | 2024-04-01 |
| Unknown | Post-COVID-19 Condition: Observational Study in Vietnam Post COVID-19 Condition | — | 2023-12-01 |
| Active Not Recruiting | Implementation and Effectiveness of Physical Activity to Prevent Disability in HIV-infected Adults Older Than HIV Infections, Cardiovascular Diseases, Insulin Resistance Syndrome X | N/A | 2023-10-31 |
| Active Not Recruiting | Community Intervention to Eliminate HCV Among People Who Use Drugs. HCV, Substance Use Disorders | N/A | 2023-10-02 |
| Recruiting | DRug Use & Infections in ViEtnam: TuBerculosis Control Tuberculosis | N/A | 2023-10-02 |
| Unknown | HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population Human Papillomavirus Infection, Human Immunodeficiency Virus Infection, Sexually Transmitted Diseases | — | 2023-10-01 |
| Unknown | Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users Monkey Pox, HIV Infections | — | 2023-09-01 |
| Active Not Recruiting | Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia HCV Infection | N/A | 2023-08-07 |
| Recruiting | OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled St COVID-19, Immunodeficiency | Phase 2 | 2023-04-27 |
| Recruiting | Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis Tuberculous Meningitis, HIV I Infection | Phase 2 | 2023-04-11 |
| Unknown | Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 HIV Infections | N/A | 2023-03-20 |
| Recruiting | Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease Monkeypox, Mpox | Phase 3 | 2023-03-03 |
| Unknown | Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults Severe Acute Respiratory Infection (SARI), Influenza, COVID-19 | — | 2023-01-20 |
| Completed | Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectab HIV-1-infection, Subtype b | Phase 1 | 2022-12-14 |
| Completed | Aging With HIV and Neurocognitive Decline, a Follow-up Study HIV Infections | N/A | 2022-11-14 |
| Unknown | Variants of SARS-CoV-2 Causing COVID-19 in Africa COVID-19 | — | 2022-09-01 |
| Completed | A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Co Healthy Adults | Phase 1 | 2022-08-05 |
| Unknown | Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Wom Hepatitis B Virus - Chronic Active | Phase 4 | 2022-07-01 |
| Terminated | Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical HIV Seropositivity | — | 2022-06-21 |
| Completed | A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02) HIV-1-infection | Phase 2 | 2022-06-21 |
| Unknown | Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine COVID-19, Vaccine Reaction, SARS CoV 2 Infection | Phase 2 | 2022-06-02 |
| Unknown | Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Infections | — | 2022-05-01 |
| Unknown | Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea COVID-19, Vaccine Adverse Reaction, Sars-CoV-2 Infection | Phase 2 | 2022-04-25 |
| Completed | Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Supp Tuberculosis, HIV-1-infection, Immuno-Deficiency | Phase 3 | 2022-04-21 |
| Completed | Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia Hepatitis C, Testing | N/A | 2022-04-21 |
| Completed | Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users Psychiatric Disorder, Drug Use | N/A | 2022-03-28 |
| Unknown | Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Mother to Child HIV Transmission | — | 2022-03-01 |
| Unknown | Prevention of Mental Health Problems Among Persons Without Personal Housing in the Context of the COVID-19 Epi Psychological Distress, Quality of Life, Psychosocial Intervention | N/A | 2022-03-01 |
| Completed | Health and Migration Trajectories of Housekeepers in Bamako HIV Infections, Hepatitis B, Hepatitis C | — | 2022-02-28 |
| Unknown | ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Hepatitis B, Chronic | Phase 2 | 2022-02-01 |
| Completed | Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authori COVID-19, Immunocompromised Host | — | 2022-01-26 |
| Unknown | Prophylaxis Vaccine Antibodies Ebola Ebola Virus Disease | Phase 2 | 2021-10-17 |
| Completed | Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment U SARS-CoV Infection, Covid19 | — | 2021-09-21 |
| Completed | Transmission of Covid-19 During Clubbing Events in Closed Places Healthy Participant | N/A | 2021-09-04 |
| Unknown | Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals Influenza -Like Illness, Covid19 | — | 2021-08-01 |
| Unknown | Partner Notification of Sexually Transmitted Infections (STIs) in Testing Centers STI, Hiv | — | 2021-07-12 |
| Unknown | Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infec Papillomavirus Infections, HIV Infections | — | 2021-06-24 |
| Unknown | Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week HIV Infections | Phase 3 | 2021-06-21 |
| Withdrawn | Protective Measures Against SARS-CoV-2 Contamination of Young Healthy Volunteers During a Concert of Actual Mu Corona Virus Infection | N/A | 2021-05-01 |
| Unknown | ANRS 12406 EvvA Study HIV-1-infection | — | 2021-04-15 |
| Completed | HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Men Who Have Sex With Men, People Living With HIV | — | 2021-04-14 |
| Unknown | Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 | Phase 2 / Phase 3 | 2021-04-12 |
| Completed | Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Healthy Adults | Phase 1 | 2021-03-29 |
| Unknown | Covid-19 Vaccine Cohort in Specific Populations Immune Deficiency | — | 2021-03-25 |
| Unknown | Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | — | 2021-03-11 |
| Completed | BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Healthy, Immunization; Infection | Phase 2 | 2021-03-08 |
| Recruiting | Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis Tuberculous Meningitis | Phase 3 | 2021-02-07 |
| Completed | Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Teno Unsafe Sex, Risk-Taking | Phase 3 | 2021-01-19 |
| Unknown | ANRS 12392 Sanu Gundo HIV Infections | N/A | 2020-11-29 |
| Completed | Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase COVID-19, COVID-19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 | Phase 2 / Phase 3 | 2020-11-27 |
| Completed | National Survey About Trajectory and Life Conditions of HIV Trans People in France HIV Seropositivity | — | 2020-10-01 |
| Unknown | ANRS 12372 MODERATO Study HIV-1-infection | Phase 3 | 2020-09-21 |
| Completed | A Community-based Intervention Among Active Drug Users in Montpellier Drug Use, HCV Infection | N/A | 2020-09-18 |
| Unknown | Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Reg Hepatitis C Virus Infection, Past or Present, Chronic Hepatitis c | — | 2020-07-14 |
| Recruiting | National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses Hepatitis D, Chronic, Hepatitis B, Chronic | — | 2020-02-19 |
| Completed | Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated HIV-1 Infection | N/A | 2020-02-10 |
| Unknown | Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset Tuberculosis | — | 2020-01-21 |
| Completed | Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention HIV-1 | Phase 3 | 2019-12-14 |
| Unknown | Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV HIV-1 | Phase 2 | 2019-12-04 |
| Unknown | Reducing Antiretroviral Treatments HIV-1-infection | Phase 3 | 2019-11-27 |
| Unknown | Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'Ivoire HIV Infections, Viral Hepatitis B, Sexually Transmitted Diseases | N/A | 2019-11-26 |
| Unknown | HUSH Restriction in HIV Infected Patients HIV Infections | — | 2019-10-01 |
| Unknown | HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, HIV Seropositivity, HCV Infection | — | 2019-09-01 |
| Unknown | ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali HIV Seropositivity, Disclosure, Empowerment | — | 2019-05-27 |
| Unknown | Frailty in People Living With HIV Aged 70 Years or More HIV Infections | N/A | 2019-05-15 |
| Unknown | Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women HIV Infections, HPV - Anogenital Human Papilloma Virus Infection | N/A | 2019-03-01 |
| Terminated | An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection HIV-1-infection | Phase 1 / Phase 2 | 2019-02-20 |
| Completed | DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) Hepatitis C, Drug Use, Viral Hepatitis C | Phase 4 | 2018-11-13 |
| Unknown | Evaluation of Third-line cART Regimen in Cambodia (3DICAM) HIV/AIDS | Phase 2 | 2018-10-04 |
| Unknown | Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection HIV I Infection | — | 2018-09-01 |
| Completed | A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on HIV Infections | — | 2018-06-28 |
| Withdrawn | Methylphenidate for Cocaine Dependence Substance-Related Disorders | Phase 2 | 2018-06-01 |
| Unknown | Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients HIV Infection, Tuberculosis Infection | — | 2018-03-01 |
| Unknown | "Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis Chronic Hepatitis C | — | 2018-01-22 |
| Unknown | ANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint) HIV Infected Patients With Cancer Treated by ICPi | — | 2018-01-17 |
| Completed | Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP) HIV/AIDS | N/A | 2017-11-20 |
| Completed | Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal Chronic Hepatitis b | — | 2017-10-19 |
| Unknown | Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission Hepatitis B Chronic Infection, Pregnancy | Phase 4 | 2017-10-04 |
| Completed | Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected P HIV Infections | Phase 3 | 2017-09-07 |
| Unknown | Prevention of HIV in "Île-de-France" HIV Infections | N/A | 2017-05-03 |
| Completed | National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HI HIV-1 Infection | Phase 3 | 2017-04-11 |
| Completed | Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety Growth and Development | — | 2017-02-27 |
| Completed | HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure Mother to Child HIV Transmission | Phase 4 | 2017-02-22 |
| Unknown | Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C Exposure to Hepatitis C Virus | — | 2017-02-21 |
| Completed | Gut-Associated Lymphocyte Trafficking HIV-1 Infection | N/A | 2017-02-06 |
| Completed | PoC-HCV Genedrive Viral Detection Assay Validation Study Hepatitis C | — | 2016-09-01 |
| Completed | Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immun HIV Infection | — | 2016-08-01 |
| Completed | Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors Maternal-fetal Infection Transmission | Phase 2 | 2016-07-06 |
| Completed | Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resou HIV-1 Infection | Phase 3 | 2016-07-01 |
| Unknown | CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children) HIV Infection | N/A | 2016-06-01 |
| Completed | Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between th HIV-1 Infection | N/A | 2016-01-26 |
| Completed | First-Line Treatment for HIV-2 HIV-2 Infection | Phase 2 / Phase 3 | 2016-01-26 |
| Completed | Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Ge Hepatitis C | Phase 2 | 2016-01-01 |
| Unknown | A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANR HIV, HIV-uninfected Children, Children Exposed to HIV | N/A | 2015-12-01 |
| Completed | Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for th Hepatitis C, HIV Infection | Phase 2 | 2015-10-01 |
| Completed | A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunode HIV-1 Infection | Phase 2 | 2015-09-17 |
| Completed | Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis HIV-1 Infection, Tuberculosis | Phase 3 | 2015-09-11 |
| Unknown | Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS Cryptococcal Meningitis | N/A | 2015-07-01 |
| Completed | Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan HIV Infection | N/A | 2015-06-01 |
| Completed | Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients HIV INFECTION | Phase 2 | 2015-03-01 |
| Unknown | Qualification of Point-of-Care Assays for Management of HCV Patients Hepatitis C | — | 2015-03-01 |
| Completed | Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Pati HIV-1 Infection | Phase 2 | 2015-01-01 |
| Completed | Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men Hiv Infection | N/A | 2014-12-02 |
| Completed | Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients HIV-1 Infection | — | 2014-12-01 |
| Terminated | Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR) HIV-1 Infection, Treatment Resistant Disorders, Viremia | Phase 3 | 2014-12-01 |
| Withdrawn | Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in Hepatitis C Virus Genotype 4 Infection | Phase 2 | 2014-12-01 |
| Completed | Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa HIV, Reproductive Health, Disability | — | 2014-11-01 |
| Completed | Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults HIV-1 Infection | Phase 4 | 2014-09-01 |
| Completed | Feasibility of Interventions on People Who Inject Drugs in Vietnam HIV, Hepatitis Virus, Substance Abuse | — | 2014-09-01 |
| Completed | Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experie Viral Hepatitis C, HIV | Phase 2 | 2014-08-01 |
| Completed | 4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients HIV-1 Infection | Phase 3 | 2014-07-01 |
| Completed | Evaluation of Raltegravir During the Third Trimester of Pregnancy HIV-1 Infection, PREGNANCY | Phase 2 | 2014-06-30 |
| Completed | IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection HIV Reservoirs | N/A | 2014-06-01 |
| Completed | Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients HIV Infection, Liver Injuries | N/A | 2014-05-01 |
| Withdrawn | Evaluation of the National Treatment Program of Hepatitis C in Egypt Chronic Hepatitis C | — | 2014-04-01 |
| Withdrawn | Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chr Chronic Hepatitis C | Phase 3 | 2014-04-01 |
| Completed | Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers HIV Infection | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Supp HIV Infection | Phase 3 | 2014-02-01 |
| Unknown | Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection Tuberculosis, HIV | Phase 2 | 2013-12-01 |
| Completed | X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study Hiv Infection | N/A | 2013-11-01 |
| Completed | Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Hepatitis C Virus Genotype 4 Infection | Phase 2 | 2013-11-01 |
| Unknown | Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection HCV Recurrence, Liver Transplantation, Direct-acting Antiviral Agents | — | 2013-10-01 |
| Completed | Prevalence of Histoplasmosis in HIV + Patients with a Rapid Diagnostic Test in West Indies HIV | — | 2013-08-01 |
| Completed | Lipopeptide Immunisation With GTU-multiHIV Trial HIV-1 Infection | Phase 2 | 2013-07-01 |
| Terminated | Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women HIV Infected Women, Healthy Women Volunteers | N/A | 2013-07-01 |
| Completed | Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients Hiv Infection | N/A | 2013-07-01 |
| Unknown | Evaluation of an Innovative Tuberculosis Diagnostic Test Tuberculosis, HIV | — | 2013-07-01 |
| Completed | Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent HIV-1 | — | 2013-04-01 |
| Unknown | Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa HIV Infection | Phase 2 | 2013-03-01 |
| Completed | National Evaluation of PI-based 2nd Line Efficacy in Cambodia HIV | — | 2013-02-01 |
| Completed | Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? HIV Infection | N/A | 2013-01-01 |
| Completed | Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patient HCV-HIV Co-Infection | Phase 2 | 2012-12-01 |
| Unknown | Therapeutic Option for Hepatitis B and C: a French Cohort Viral Hepatitis B, Viral Hepatitis C | — | 2012-08-06 |
| Completed | Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infec HIV-2 Infection | Phase 2 | 2012-07-01 |
| Unknown | Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Th Cryptococcal Meningitis, HIV | Phase 2 / Phase 3 | 2012-05-01 |
| Completed | Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence HIV Infection | N/A | 2012-03-01 |
| Withdrawn | A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or L HIV | Phase 3 | 2012-03-01 |
| Recruiting | the ANRS CO21 " Extreme " Cohort (CODEX) HIV Infection | N/A | 2012-02-01 |
| Completed | Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France HIV Infection, Chronic Hepatitis B | — | 2012-02-01 |
| Completed | On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men HIV Infection | Phase 3 | 2012-01-01 |
| Terminated | Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy Human Immunodeficiency Virus, Lipohypertrophy | Phase 2 | 2011-12-01 |
| Completed | Renal Transplantation and Raltegravir in HIV-Infected Patients HIV-1 Infection, Chronic Renal Insufficiency | Phase 3 | 2011-12-01 |
| Completed | Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected HIV-1 Infection, AIDS | Phase 3 | 2011-09-01 |
| Completed | Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretrovira HIV Infections | Phase 2 / Phase 3 | 2011-06-01 |
| Completed | Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin HCV Coinfection, HIV-1 Infection | Phase 2 | 2011-05-01 |
| Completed | Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen Hepatitis C, Chronic, HIV Infection | Phase 2 | 2011-04-01 |
| Completed | Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Fa HIV, Tuberculosis, Pediatrics | N/A | 2011-04-01 |
| Completed | Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a P Hiv Infection, Lung Cancer | N/A | 2011-02-01 |
| Completed | French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir Chronic Hepatitis C | — | 2011-02-01 |
| Unknown | A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alph Chronic Hepatitis B, AgHbs Negativation | Phase 3 | 2011-01-01 |
| Completed | Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and HIV Infection, Hepatitis B | — | 2010-12-01 |
| Completed | Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral na HIV Infections | Phase 3 | 2010-08-01 |
| Completed | Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon HIV Infections | — | 2010-06-01 |
| Completed | Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients HIV Infection, Liver Failure, Evidence of Liver Transplantation | Phase 1 / Phase 2 | 2010-05-01 |
| Completed | Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM) HIV-1 Infections | Phase 3 | 2010-04-01 |
| Unknown | Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg Chronic Hepatitis C | Phase 2 | 2010-03-01 |
| Completed | Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yao HIV, HIV Infections | Phase 3 | 2009-11-01 |
| Completed | Efficacy and Safety of Varenicline Among HIV-infected Patients HIV Infections, Tobacco Dependence | Phase 3 | 2009-10-01 |
| Completed | Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tube HIV Infections, Tuberculosis | Phase 2 | 2009-07-01 |
| Completed | ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response Hepatitis | Phase 2 | 2009-06-01 |
| Completed | Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults HIV Infections | Phase 2 | 2009-05-01 |
| Terminated | Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials HIV Infection, HIV Seronegativity | — | 2008-12-01 |
| Completed | Cohort of HIV Associated Lymphomas HIV Infection | — | 2008-06-01 |
| Completed | Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to P Hepatitis B, HIV Infection | Phase 3 | 2008-05-01 |
| Active Not Recruiting | Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project HIV | — | 2007-11-01 |
| Completed | Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers HIV Infections | Phase 1 / Phase 2 | 2007-07-01 |
| Completed | Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients HIV Infections | Phase 3 | 2007-06-01 |
| Completed | Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors i HIV Infections | Phase 2 / Phase 3 | 2007-03-01 |
| Unknown | Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV) Chronic Hepatitis C | — | 2006-11-01 |
| Completed | Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C Hepatitis C, Chronic | Phase 3 | 2006-10-01 |
| Completed | Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha Hepatitis C, Chronic, Liver Fibrosis | Phase 2 / Phase 3 | 2006-05-01 |
| Completed | Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis Carcinoma, Hepatocellular, Hepatitis, Viral, Human | Phase 3 | 2005-07-01 |
| Completed | Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV HIV, Hepatitis C | — | 2005-06-01 |
| Unknown | National Cohort of Children Born to HIV-positive Mothers Mother to Child Transmission of HIV | — | 2005-06-01 |
| Completed | Cohort of HIV-infected Children Children Infected by HIV | — | 2004-07-01 |
| Completed | Cohort of Patients Naive of Antiretroviral Treatment at Enrollment HIV Infection | — | 2004-02-01 |
| Completed | Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire HIV Infection | — | 1997-06-01 |
| Unknown | Primary Infection Cohort HIV-1-infection | — | 1996-10-01 |
| Unknown | Cohorte Nationale VIH-2 HIV-2 Infection | — | 1994-01-01 |